NSIS-B:CPH
Novozymes A/S
DKKÂ 450.60
arrow_downward
-0.38%(-1.70) 1D
Aug 21, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKKÂ 450.70
High
DKKÂ 454.00
Low
DKKÂ 441.30
Mkt. cap
187.50B
Avg. vol.
453.64K
Volume
715.68K
52-wk high
DKKÂ 454.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKKÂ 450.70
High
DKKÂ 454.00
Low
DKKÂ 441.30
Mkt. cap
187.50B
Avg. vol.
453.64K
Volume
715.68K
52-wk high
DKKÂ 454.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
Ad-hoc-news.de
·
51 minutes ago
Novonesis stock lifts on buyback signal and Q2 beat
CNBC
·
1 day ago
Novonesis CEO: Earnings put us in a good place
Investing.com
·
1 day ago
Earnings call transcript: Novonesis raises 2026 outlook as shares jump 8.5%
Benzinga
·
1 day ago
Novozymes Reports H1 2026 Results: Full Earnings Call Transcript
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
AI content may include mistakes. Learn more